Pediatrix Medical Debt to Equity Ratio 2010-2024 | MD
Current and historical debt to equity ratio values for Pediatrix Medical (MD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pediatrix Medical debt/equity for the three months ending March 31, 2024 was 0.83.
| Pediatrix Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $1.31B | $0.86B | 1.53 |
| 2023-12-31 | $1.37B | $0.85B | 1.61 |
| 2023-09-30 | $1.36B | $0.97B | 1.40 |
| 2023-06-30 | $1.36B | $0.94B | 1.45 |
| 2023-03-31 | $1.41B | $0.91B | 1.55 |
| 2022-12-31 | $1.46B | $0.89B | 1.63 |
| 2022-09-30 | $1.47B | $0.86B | 1.72 |
| 2022-06-30 | $1.52B | $0.85B | 1.80 |
| 2022-03-31 | $1.46B | $0.88B | 1.67 |
| 2021-12-31 | $1.83B | $0.90B | 2.04 |
| 2021-09-30 | $1.80B | $0.85B | 2.13 |
| 2021-06-30 | $1.75B | $0.81B | 2.16 |
| 2021-03-31 | $1.72B | $0.77B | 2.24 |
| 2020-12-31 | $2.60B | $0.75B | 3.48 |
| 2020-09-30 | $2.62B | $0.81B | 3.25 |
| 2020-06-30 | $2.56B | $0.83B | 3.10 |
| 2020-03-31 | $2.83B | $1.49B | 1.90 |
| 2019-12-31 | $2.65B | $1.50B | 1.77 |
| 2019-09-30 | $2.81B | $1.48B | 1.90 |
| 2019-06-30 | $2.91B | $2.73B | 1.07 |
| 2019-03-31 | $2.93B | $2.78B | 1.05 |
| 2018-12-31 | $2.85B | $3.09B | 0.92 |
| 2018-09-30 | $2.82B | $3.02B | 0.94 |
| 2018-06-30 | $2.67B | $3.19B | 0.84 |
| 2018-03-31 | $2.74B | $3.14B | 0.87 |
| 2017-12-31 | $2.80B | $3.07B | 0.91 |
| 2017-09-30 | $2.76B | $2.92B | 0.95 |
| 2017-06-30 | $2.57B | $2.84B | 0.91 |
| 2017-03-31 | $2.66B | $2.76B | 0.96 |
| 2016-12-31 | $2.58B | $2.76B | 0.93 |
| 2016-09-30 | $2.68B | $2.67B | 1.00 |
| 2016-06-30 | $2.21B | $2.56B | 0.87 |
| 2016-03-31 | $2.18B | $2.46B | 0.88 |
| 2015-12-31 | $2.11B | $2.44B | 0.87 |
| 2015-09-30 | $2.21B | $2.33B | 0.95 |
| 2015-06-30 | $2.06B | $2.22B | 0.93 |
| 2015-03-31 | $1.53B | $2.11B | 0.73 |
| 2014-12-31 | $1.34B | $2.27B | 0.59 |
| 2014-09-30 | $0.97B | $2.51B | 0.39 |
| 2014-06-30 | $0.77B | $2.41B | 0.32 |
| 2014-03-31 | $0.79B | $2.31B | 0.34 |
| 2013-12-31 | $0.67B | $2.34B | 0.28 |
| 2013-09-30 | $0.75B | $2.23B | 0.33 |
| 2013-06-30 | $0.70B | $2.19B | 0.32 |
| 2013-03-31 | $0.69B | $2.11B | 0.33 |
| 2012-12-31 | $0.72B | $2.04B | 0.35 |
| 2012-09-30 | $0.58B | $1.95B | 0.30 |
| 2012-06-30 | $0.48B | $1.87B | 0.26 |
| 2012-03-31 | $0.53B | $1.80B | 0.29 |
| 2011-12-31 | $0.54B | $1.73B | 0.31 |
| 2011-09-30 | $0.52B | $1.66B | 0.31 |
| 2011-06-30 | $0.48B | $1.59B | 0.30 |
| 2011-03-31 | $0.56B | $1.51B | 0.37 |
| 2010-12-31 | $0.59B | $1.45B | 0.41 |
| 2010-09-30 | $0.43B | $1.37B | 0.31 |
| 2010-06-30 | $0.46B | $1.30B | 0.35 |
| 2010-03-31 | $0.50B | $1.24B | 0.41 |
| 2009-12-31 | $0.50B | $1.19B | 0.42 |
| 2009-09-30 | $0.54B | $1.12B | 0.48 |
| 2009-06-30 | $0.53B | $1.06B | 0.50 |
| 2009-03-31 | $0.52B | $1.01B | 0.51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.760B | $1.995B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.615B | 15.64 |
| Cencora (COR) | United States | $45.231B | 17.63 |
| ICON (ICLR) | Ireland | $25.948B | 24.50 |
| DiDi Global (DIDIY) | China | $24.059B | 0.00 |
| Avantor (AVTR) | United States | $16.880B | 24.85 |
| CochLear (CHEOY) | Australia | $14.219B | 0.00 |
| Viatris (VTRS) | United States | $13.955B | 4.01 |
| Revvity (RVTY) | United States | $12.744B | 22.33 |
| Medpace Holdings (MEDP) | United States | $12.458B | 40.99 |
| Charles River Laboratories (CRL) | United States | $12.172B | 22.19 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.058B | 0.00 |
| Natera (NTRA) | United States | $11.732B | 0.00 |
| Solventum (SOLV) | United States | $11.310B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.460B | 0.00 |
| HealthEquity (HQY) | United States | $6.897B | 51.53 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.99 |
| Doximity (DOCS) | United States | $4.546B | 33.85 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.530B | 32.29 |
| Sotera Health (SHC) | United States | $3.247B | 15.93 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| GoodRx Holdings (GDRX) | United States | $2.974B | 150.60 |
| Life Times (LTH) | United States | $2.968B | 31.44 |
| Premier (PINC) | United States | $2.326B | 8.70 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.184B | 0.00 |
| Agilon Health (AGL) | United States | $2.047B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.967B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.671B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.481B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.314B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.607B | 4.01 |
| InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
| CareDx (CDNA) | United States | $0.543B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.529B | 0.00 |
| LifeMD (LFMD) | United States | $0.506B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.504B | 0.00 |
| Enhabit (EHAB) | United States | $0.497B | 45.00 |
| Auna S.A (AUNA) | Luxembourg | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.416B | 0.00 |
| ModivCare (MODV) | United States | $0.374B | 7.00 |
| DocGo (DCGO) | United States | $0.371B | 59.33 |
| Sera Prognostics (SERA) | United States | $0.307B | 0.00 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.178B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.17 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |